PMID- 28381728
OWN - NLM
STAT- MEDLINE
DCOM- 20180312
LR  - 20180312
IS  - 1881-2090 (Electronic)
IS  - 0023-5679 (Linking)
VI  - 63
IP  - 3.4
DP  - 2017 May 8
TI  - The Effects of Psychoeducation on Long-term Inpatients with Schizophrenia and 
      Schizoaffective Disorder.
PG  - 61-67
LID - 10.2739/kurumemedj.MS00011 [doi]
AB  - This study aimed to examine the significance of intervention to improve 
      medication adherence in long-term inpatients by providing psychoeducation and 
      then elucidating the effects of this training in terms of patient knowledge and 
      attitudes. Subjects were patients who had been hospitalized for more than 1 year 
      after being admitted to a psychiatric hospital, had been diagnosed as F2 
      (schizophrenia, schizoaffective disorder) according to the International 
      Classification of Diseases, 10th Edition, and were capable of verbal 
      communication. Patients suspected of having dementia were excluded. Items 
      surveyed were patient background, prescriptions, Global Assessment of Functioning 
      (GAF) score, Drug Attitude Inventory-10 (DAI-10) score, and Knowledge of Illness 
      and Drugs Inventory (KIDI) score. The amount of medication taken and GAF, DAI-10, 
      and KIDI scores were evaluated within 1 week of starting psychoeducation and 
      within 1 week of completing psychoeducation. The Wilcoxon signed-rank test and 
      McNemar test was used to compare scores before and after intervention. The mean 
      overall KIDI score increased significantly, and the mean overall DAI-10 score 
      improved significantly after intervention. Furthermore, the mean overall KIDI 
      score of very long-term inpatients with schizophrenia and schizoaffective 
      disorder increased significantly after intervention. Psychoeducation produced 
      improvement in some areas of knowledge and attitudes towards medication among 
      long-term inpatients. These results demonstrate that psychoeducation has an 
      effect on long-term inpatients that is similar to the effect observed in earlier 
      studies on patients leading community lives, including patients who have just 
      been admitted or discharged and patients attending day care or outpatient visits.
FAU - Yanagida, Nobuhiko
AU  - Yanagida N
AD  - Department of Occupational Therapy, School of Health Sciences, Faculty of 
      Medicine, Kagoshima University.
FAU - Uchino, Toshiro
AU  - Uchino T
AD  - Department of Psychiatry, Kurume University School of Medicine.
FAU - Uchimura, Naohisa
AU  - Uchimura N
AD  - Department of Psychiatry, Kurume University School of Medicine.
LA  - eng
PT  - Journal Article
DEP - 20170403
PL  - Japan
TA  - Kurume Med J
JT  - The Kurume medical journal
JID - 2985210R
RN  - 0 (Antipsychotic Agents)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Antipsychotic Agents/adverse effects/*therapeutic use
MH  - Female
MH  - *Health Knowledge, Attitudes, Practice
MH  - Humans
MH  - *Inpatients
MH  - Length of Stay
MH  - Male
MH  - *Medication Adherence
MH  - Middle Aged
MH  - Patient Education as Topic/*methods
MH  - Psychiatric Status Rating Scales
MH  - Psychotic Disorders/diagnosis/*drug therapy/psychology
MH  - Schizophrenia/diagnosis/*drug therapy
MH  - *Schizophrenic Psychology
MH  - Surveys and Questionnaires
MH  - Time Factors
MH  - Treatment Outcome
OTO - NOTNLM
OT  - knowledge
OT  - long-term inpatients
OT  - medication adherence
OT  - psychoeducation
OT  - schizophrenia
EDAT- 2017/04/07 06:00
MHDA- 2018/03/13 06:00
CRDT- 2017/04/07 06:00
PHST- 2017/04/07 06:00 [pubmed]
PHST- 2018/03/13 06:00 [medline]
PHST- 2017/04/07 06:00 [entrez]
AID - 10.2739/kurumemedj.MS00011 [doi]
PST - ppublish
SO  - Kurume Med J. 2017 May 8;63(3.4):61-67. doi: 10.2739/kurumemedj.MS00011. Epub 
      2017 Apr 3.